Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CYTOSORBENTS CORPORATION

(CTSO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Inch Higher Ahead of Wednesday Open

09/01/2021 | 08:45am EST


ę MT Newswires 2021
All news about CYTOSORBENTS CORPORATION
11/15CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Healt..
PR
11/04CYTOSORBENTS : Q3 Earnings Snapshot
AQ
11/04Third Quarter 2021 total revenue was $9.8 million, including product sales of $8.9 mill..
PU
11/04CYTOSORBENTS CORP : Results of Operations and Financial Condition (form 8-K)
AQ
11/04Earnings Flash (CTSO) CYTOSORBENTS CORPORATION Posts Q3 Loss $-0.15, vs. Street Est of ..
MT
11/04Earnings Flash (CTSO) CYTOSORBENTS CORPORATION Posts Q3 Revenue $9.8M, vs. Street Est o..
MT
11/04CYTOSORBENTS CORP Management's Discussion and Analysis of Financial Condition and Resu..
AQ
11/04CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results
PR
11/04Cytosorbents Corporation Reaffirms Revenue Guidance for the Fourth Quarter and Full Yea..
CI
11/04Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months..
CI
More news
Analyst Recommendations on CYTOSORBENTS CORPORATION
More recommendations
Financials (USD)
Sales 2021 42,6 M - -
Net income 2021 -20,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -10,1x
Yield 2021 -
Capitalization 214 M 214 M -
Capi. / Sales 2021 5,02x
Capi. / Sales 2022 3,96x
Nbr of Employees 195
Free-Float 91,6%
Chart CYTOSORBENTS CORPORATION
Duration : Period :
Cytosorbents Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CYTOSORBENTS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 4,75 $
Average target price 12,00 $
Spread / Average Target 153%
EPS Revisions
Managers and Directors
Phillip P. Chan Chief Executive Officer & Director
Vincent J. Capponi President & Chief Operating Officer
Kathleen P. Bloch Chief Financial Officer & Secretary
Al W. Kraus Independent Non-Executive Chairman
Steven Sisk Director-Clinical Operations
Sector and Competitors